Stop TB Partnership

Coordinating Board

The Stop TB Partnership Coordinating Board provides leadership and direction, monitors the implementation of agreed policies, plans and activities of the Partnership, and ensures coordination among Stop TB Partnership components.

Board Functions

• Formulate priorities for action by the partnership in line with health policy and technical advice from WHO and in the light of the recommendations of the Partners Forum;
• Support the Partners according to agreed strategy;
• Approve the work plan and budget of the Secretariat, provide leadership and direction and monitor its implementation;
• Mobilize adequate resources for the various activities of the Stop TB Partnership after identifying funding gaps with respect to approved work plans and assigning priorities to different elements of the work plans;
• Coordinate and promote advocacy and social mobilization in support of the Stop TB Partnership in appropriate fora;
• Review the progress of the implementation of the Stop TB Partnership and maintain a program of frequent, high-quality information exchange, including reports of its meetings, with all Partners and the public at large;
• To provide oversight and review of the use of the Stop TB Partnership Trust Fund;
• Review the annual financial statement and progress report prepared by the Executive Secretary;
• Adopt an appropriate financial policy to underpin financial decisions and accounting for resources entrusted to the Stop TB Secretariat;
• Coordinate input to Partnership processes and initiatives from the constituencies represented on the Board;
• Represent the Stop TB Partnership in external fora and events;
• Adopt appropriate rules or guidelines to ensure the proper running of the Stop TB Partnership;
• Establish such committees, working groups and task forces as it may deem necessary;
• Consider and approve any amendment to the Basic Framework; and
• Consider any other matter related to the Stop TB Partnership as may be referred to it by any of its members, by the Chair of the Board, by the Executive Committee (ExCom), or by the Executive Secretary.

Board Composition

The composition of the Coordinating Board shall represent the component constituencies of the Partnership. The Board shall be composed of 34 members in the following manner and shall be reviewed by the Board in the light of any evaluation of the Partnership:

• 4 representatives from high burden countries,
• 3 representatives, one from each of WHO, the World Bank and the GFATM ,
• 1 representative of another international organization,
• 6 regional representatives, assuring the inclusion of representatives from non-high burden countries,
• 7 Working Group Chairpersons representing DOTS Expansion, MDR-TB, TB-HIV, Diagnostics, TB Drug Development, New Vaccines and Global Laboratory Initiative,
• 5 representatives of financial donors,
• 1 representative of Foundations,
• 3 representatives of NGOs and technical agencies, including The Union and CDC as permanent members,
• 2 representatives of communities affected by TB,
• The Chair of the WHO STAG, and
• 1 representative of the corporate business sector